P8A:SGX
Cordlife Group Ltd
SGD 0.12
0.00%
(0.00) 1D
Oct 12, 9:49:20 AM GMT+8 · SGD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for P8A...
Mkt. cap
32.37M
Avg. vol.
1.32K
Volume
0.00
52-wk high
SGD 0.26
52-wk low
SGD 0.10
EPS
-SGD 0.04
Shares outstanding
267.53M
No. of employees
111
Mkt. cap
32.37M
Avg. vol.
1.32K
Volume
0.00
52-wk high
SGD 0.26
52-wk low
SGD 0.10
EPS
-SGD 0.04
Shares outstanding
267.53M
No. of employees
111
News stories
From web sources and news partners
Yahoo Finance
·
51 minutes ago
3 Reasons the Vanguard S&P 500 ETF Could Be Worth Holding for the Next 20 Years
ad-hoc-news.de
·
2 hours ago
Dow reports on October 22, 2026: Dow stock stands at USD 29.93
Traders Union
·
7 hours ago
S&P 500 posts one new low for second day, Ryan Detrick notes
TOKENPOST
·
3 hours ago
S&P 500 Earnings Season Shows 83% of Early Firms Beat Estimates
Profile
Cordlife Group Limited, is a consumer health company incorporated in May 2001 and a provider of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
Cordlife Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six markets including Singapore, Hong Kong, India, Indonesia, and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
Cordlife's stem cell processing and storage facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia were accredited by AABB until 2024 when its accreditation was withdrawn.
In November 2023, the Ministry of Health of Singapore revealed that Cordlife Group had exposed cryopreserved cord blood units at suboptimal temperatures, damaging the cord blood units belonging to at least 2,150 clients and rendering them unsuitable for stem cell transplant purposes. Wikipedia
About Cordlife Group Ltd
CEOYiu Pang Fai
Employees111
FoundedMay 2, 2001
Headquarters-
SectorHealth care provider
Websitecordlife.com